Contributor #L-6275
Anonymous submitter. Hormonal class against pharmacopoeial limits.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.04%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043207 | GHK-Cu | SGN | SGN-2603-X8452 | PeptideMeter | 2026-Q2 | 98.16 | 3.89 | 91.6 | Buyer-sourced | 0 | PASS |
| AX-2026-041710 | Tirzepatide | TFS | TFS-{CAT}-1353 | Janoshik | 2026-Q1 | 99.06 | 4.25 | 102.7 | Buyer-sourced | 0 | PASS |
| AX-2025-018757 | Tirzepatide | QSC | QSC-2510-D7439 | Nordanalyt | 2025-Q4 | 99.38 | 3.88 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020615 | SS-31 (Elamipretide) | GL Biochem | GLBI-2507-R8080 | PeptideMeter | 2025-Q3 | 98.50 | 3.11 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018502 | MOTS-c | WWB | WWB-2505-G2801 | Janoshik | 2025-Q3 | 99.41 | 3.65 | 103.8 | Buyer-sourced | 0 | PASS |
| AX-2025-018697 | TB-500 | QSC | QSC-2504-T6759 | Janoshik | 2025-Q2 | 99.82 | 3.17 | 96.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019241 | AOD-9604 | AMB | AMB-2411-S5560 | VendorInvestigate | 2025-Q2 | 99.02 | 4.86 | 96.1 | Buyer-sourced | 0 | PASS |
| AX-2025-018901 | Retatrutide | TFS | TFS-{CAT}-9723 | Janoshik | 2025-Q1 | 98.83 | 4.97 | 99.6 | Buyer-sourced | 0 | PASS |